Kidney transplant patients at Emory Transplant Center who were given medication to prevent organ rejection and strengthen their immune system every two months instead of monthly were found to be just as healthy, based...
Emory Transplant Center patient Sherrell Gay was given a second chance at life, twice. On New Year’s Day, Sherrell was able to honor those who gave her the gift of life in the 131st...
Devin Gerald, a kidney transplant patient with the Emory Kidney Transplant Program, describes his experience growing up with kidney disease. Eventually, in his late teens, Devin’s kidneys started to fail, and he found himself...
Made possible by the HIV Organ Policy Equity (HOPE) Act, Emory Transplant Center has performed its first HIV-positive kidney transplant from an HIV-positive deceased donor. Not only was this Emory’s first HIV to HIV...
Emory Transplant Center will soon begin enrolling patients into a new clinical trial that will test an FDA-approved drug in HIV positive patients receiving a kidney transplant. The research study will evaluate the safety...
The National Institutes of Minority Health and Health Disparities has awarded $2.6 million over five years to the Emory Transplant Center and six other transplant centers and organizations in the Southeastern Kidney Transplant Coalition....
A study of kidney transplant recipients has shown for the first time that the drug belatacept (Nulojix), which controls the immune system and prevents graft rejection, has a better record of patient and organ...
The team at the Emory Transplant Center has performed more organ transplants in the state of Georgia than any other transplant center. Because the Georgia community trusts the expertise of our transplant team, we...